JP2024546513A5 - - Google Patents
Info
- Publication number
- JP2024546513A5 JP2024546513A5 JP2024539614A JP2024539614A JP2024546513A5 JP 2024546513 A5 JP2024546513 A5 JP 2024546513A5 JP 2024539614 A JP2024539614 A JP 2024539614A JP 2024539614 A JP2024539614 A JP 2024539614A JP 2024546513 A5 JP2024546513 A5 JP 2024546513A5
- Authority
- JP
- Japan
- Prior art keywords
- phosphate
- dsodium
- sodium
- approximately
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2021/000916 WO2023126637A1 (en) | 2021-12-29 | 2021-12-29 | Compositions containing fexofenadine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024546513A JP2024546513A (ja) | 2024-12-24 |
| JP2024546513A5 true JP2024546513A5 (https=) | 2025-01-10 |
| JP7826492B2 JP7826492B2 (ja) | 2026-03-09 |
Family
ID=80122351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539614A Active JP7826492B2 (ja) | 2021-12-29 | 2021-12-29 | フェキソフェナジン含有組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250082623A1 (https=) |
| EP (1) | EP4456880B1 (https=) |
| JP (1) | JP7826492B2 (https=) |
| KR (1) | KR20240136358A (https=) |
| CN (1) | CN118715004A (https=) |
| AR (1) | AR128113A1 (https=) |
| AU (1) | AU2021480621A1 (https=) |
| CA (1) | CA3242293A1 (https=) |
| CO (1) | CO2024009774A2 (https=) |
| MX (1) | MX2024008242A (https=) |
| PE (1) | PE20242355A1 (https=) |
| WO (1) | WO2023126637A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026074306A1 (en) | 2024-10-03 | 2026-04-09 | Opella Healthcare Group Sas | Chewable fexofenadine tablets |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
| DOP2006000274A (es) * | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
| CN102958515A (zh) * | 2009-12-02 | 2013-03-06 | 阿普塔利斯制药有限公司 | 非索非那定微胶囊及含有非索非那定微胶囊的组合物 |
| FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
| CN102512389B (zh) * | 2011-12-27 | 2013-08-21 | 天津市嵩锐医药科技有限公司 | 非索非那定盐酸盐口腔崩解药物组合物 |
| KR101761983B1 (ko) * | 2014-08-25 | 2017-08-07 | 아주대학교산학협력단 | 구강내 속붕해 필름 조성물 및 그 제조방법 |
| CN105997910A (zh) * | 2016-06-09 | 2016-10-12 | 北京化工大学 | 一种掩味制剂及其制备方法 |
-
2021
- 2021-12-29 KR KR1020247025570A patent/KR20240136358A/ko active Pending
- 2021-12-29 PE PE2024001517A patent/PE20242355A1/es unknown
- 2021-12-29 CN CN202180105441.6A patent/CN118715004A/zh active Pending
- 2021-12-29 CA CA3242293A patent/CA3242293A1/en active Pending
- 2021-12-29 AU AU2021480621A patent/AU2021480621A1/en active Pending
- 2021-12-29 MX MX2024008242A patent/MX2024008242A/es unknown
- 2021-12-29 EP EP21851701.9A patent/EP4456880B1/en active Active
- 2021-12-29 JP JP2024539614A patent/JP7826492B2/ja active Active
- 2021-12-29 US US18/725,446 patent/US20250082623A1/en active Pending
- 2021-12-29 WO PCT/IB2021/000916 patent/WO2023126637A1/en not_active Ceased
-
2022
- 2022-12-27 AR ARP220103594A patent/AR128113A1/es unknown
-
2024
- 2024-07-23 CO CONC2024/0009774A patent/CO2024009774A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4740740B2 (ja) | 薬物含有粒子および該粒子を含む固形製剤 | |
| US8048449B2 (en) | Mouth dissolving pharmaceutical composition and process for preparing the same | |
| JP6054940B2 (ja) | １−（３−（２−（１−ベンゾチオフェン−５−イル）エトキシ）プロピル）アゼチジン−３−オールまたはその塩を含有する固形医薬組成物 | |
| CN110475544B (zh) | 包含氨基甲酸酯化合物的口腔崩解片 | |
| JP6153867B2 (ja) | 口腔内速崩壊性錠 | |
| KR20010034718A (ko) | 속붕해성 고형 세티리진 제형 | |
| JP2004175796A (ja) | 排尿障害治療用口腔内崩壊製剤 | |
| JP4965130B2 (ja) | 乾式直打速崩壊性錠剤 | |
| US20030161875A1 (en) | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors | |
| EP2661252A1 (en) | Water soluble dosage forms | |
| JP2024546513A5 (https=) | ||
| US20040001885A1 (en) | Rapidly disintegrating antihistamine formulation | |
| KR100604034B1 (ko) | 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물 | |
| JP7826492B2 (ja) | フェキソフェナジン含有組成物 | |
| JP3899522B2 (ja) | 苦味が低減されたプランルカスト水和物を含有する製剤 | |
| EP2959889A1 (en) | Orally disintegrating formulations of loxoprofen | |
| JP6012622B2 (ja) | ホスホマイシン医薬組成物 | |
| JP2023549381A (ja) | 抗ヒスタミン活性化合物を含む口内分散性粉末組成物 | |
| JP7023186B2 (ja) | 認知症治療薬を含有する口腔内崩壊性錠剤 | |
| JP2008094751A (ja) | プランルカスト水和物含有医薬組成物 | |
| WO2019197939A1 (en) | Taste masked mouth dissolving formulation of montelukast sodium and levocetirizine hydrochloride | |
| WO2011139255A2 (en) | Pharmaceutical compositions comprising cefetamet | |
| JP2010053048A (ja) | 苦味が緩和されたイルベサルタン含有医薬組成物 | |
| HK40111138A (zh) | 含有非索非那定的组合物 | |
| JP7049610B2 (ja) | レボセチリジン固形製剤 |